Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
iCRT3 is an inhibitor of both Wnt and β-catenin-responsive transcription
incorporates an E3 ligase ligand plus alkylC5 linker with terminal carboxylic acid ready for conjugation to a target protein ligand
which reverses the ATP-binding cassette sub-family B member 1 (ABCB1)-mediated Multidrug resistance (MDR) by selectively blocking the efflux function of ABCB1
Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder in 2011
mice tolerate treatment with carnosol without significant loss of body weight similar to the vehicle-treated group
LY 2389575 hydrochloride 17454 iCRT3 is an inhibitor ofLY2389575 is described here instead of LY2389575 hydrochloride. LY2389575 is a selective negative allosteric modulator (NAM) of metabotropic glutamate receptor 3 (mGlu3) with an IC50 value of 4. 2 M . The metabotropic glutamate receptors (mGlus) are members of the GPCR family C. They are characterized by a large extracellular amino terminal domain for binding agonist. Eight mGlus had been found and were assigned to three groups based on their
US$ 49.95
US$ 50.95
US$ 195.50
US$ 11.99
US$ 36.00
US$ 3544.00
US$ 139.99
US$ 22.00